BamSEC and AlphaSense Join Forces
Learn More

Adial Pharmaceuticals Inc – Material Contracts

NASDAQ: ADIL    
Share price (9/21/26): $4.40    
Market cap (9/21/26): $11.6 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.3
from 8-K 12 pages Adial Pharmaceuticals, Inc. 2026 Employee Stock Purchase Plan Adopted by the Board of Directors: August 12, 2026 Approved by the Stockholders: September 17, 2026
12/34/56
EX-10.2
from 8-K 21 pages Adial Pharmaceuticals, Inc. 2026 Equity Incentive Plan Adopted by the Board of Directors: August 12, 2026 Approved by the Stockholders: September 17, 2026
12/34/56
EX-10.1
from 8-K 1 page Amendment No. 8 to the Adial Pharmaceuticals, Inc. 2017 Equity Incentive Plan
12/34/56
EX-10.2
from 8-K 5 pages Amendment No. 1 to Exchange Agreement
12/34/56
EX-10.1
from 8-K 6 pages Amendment No. 2 to Securities Purchase Agreement
12/34/56
EX-10.12
from 10-Q 5 pages Amendment No. 1 to Securities Purchase Agreement
12/34/56
EX-10.11
from 10-Q 9 pages Via Email Tony Goodman Togood464@gmail.com Re: Notice of Termination of Employment
12/34/56
EX-10.10
from 10-Q 6 pages Adial Pharmaceuticals, Inc. Restricted Stock Unit Grant Notice
12/34/56
EX-10.9
from 10-Q 9 pages Adial Pharmaceuticals, Inc. Stock Option Grant Notice
12/34/56
EX-10.8
from 10-Q 17 pages Amended and Restated Executive Employment Agreement
12/34/56
EX-10.6
from 8-K 3 pages Amendment to Employment Agreement
12/34/56
EX-10.5
from 8-K 3 pages Amendment to Employment Agreement
12/34/56
EX-10.4
from 8-K 3 pages Amendment to Amended and Restated Employment Agreement
12/34/56
EX-10.3
from 8-K 21 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 35 pages Exchange Agreement
12/34/56
EX-10.1
from 8-K 38 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 8 pages Form of Adial Pharmaceuticals, Inc. Restricted Stock Award Agreement
12/34/56
EX-10.1
from 8-K 13 pages Form of Warrant Inducement Agreement, Dated November 25, 2025, by and Between Adial Pharmaceuticals, Inc. and Holder
12/34/56
EX-10.1
from 8-K 1 page Amendment No. 7 to the Adial Pharmaceuticals, Inc. 2017 Equity Incentive Plan
12/34/56
EX-10.2
from 8-K 3 pages Amendment No. 1 to Series B-1 Common Stock Purchase Warrant and Series C-1 Common Stock Purchase Warrant
12/34/56